ANAB vs REGN: Which Stock is Better?
Side-by-side comparison of Anaptysbio Inc and Regeneron Pharmaceuticals Inc in 2026
ANAB
Anaptysbio Inc
$55.67
REGN
Regeneron Pharmaceuticals Inc
$614.78
Key Metrics Comparison
| Metric | ANAB | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.69B | $65.81B | REGN |
| P/E Ratio | N/A | 15.34 | REGN |
| EPS (TTM) | $N/A | $40.93 | REGN |
| Revenue Growth | -0.1% | 0.2% | REGN |
| Gross Margin | 44.6% | 43.9% | ANAB |
Analyze ANAB
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ANAB or REGN a better investment?
Comparing ANAB and REGN: Anaptysbio Inc has a market cap of $1.69B while Regeneron Pharmaceuticals Inc has $65.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ANAB and REGN?
ANAB (Anaptysbio Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ANAB or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ANAB or REGN?
REGN has higher revenue growth at 0.2% vs -0.1% for ANAB.
Which company is more profitable: ANAB or REGN?
Anaptysbio Inc (ANAB) has higher gross margins at 44.6% compared to 43.9% for REGN.
Which is the larger company: ANAB or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $65.81B compared to $1.69B for ANAB.
Should I buy ANAB or REGN in 2026?
Both ANAB and REGN have investment merit. ANAB trades at $55.67 while REGN trades at $614.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ANAB and REGN stock?
Key differences: Market Cap ($1.69B vs $65.81B), P/E Ratio (N/A vs 15.3x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (44.6% vs 43.9%).